----item----
version: 1
id: {E33F0D94-57F4-4DAA-AC47-C446817A829C}
database: master
path: /sitecore/content/ScripIntelligence/Home/Articles/2015/09/21/PharmAsia News Business Bulletin
parent: {4B7F304D-9C2D-4432-B9EB-9C4CAC22ECA9}
name: PharmAsia News Business Bulletin
master: {00000000-0000-0000-0000-000000000000}
template: {11380B5D-3531-4570-B213-EFC5312266E4}
templatekey: Article

----version----
language: en
version: 1
revision: 8901c919-a66b-47d8-97e8-63406716736e

----field----
field: {0212FC0F-953B-461C-B4D9-B7483A4D4F1B}
name: Taxonomy
key: taxonomy
content-length: 38

{3FA7743D-5DAB-49A3-B30D-DF5079ADB082}
----field----
field: {2D750EFF-9058-4ABF-A7FF-57FFE5DA1E3C}
name: Title
key: title
content-length: 32

PharmAsia News Business Bulletin
----field----
field: {F1D1DC93-63DF-4AFA-B60F-B3A3E9D36675}
name: Sub Title
key: sub title
content-length: 32

PharmAsia News Business Bulletin
----field----
field: {446A339B-E1D9-4DE1-8B5E-DB7942EF1723}
name: Body
key: body
content-length: 4190

<p>A new regular roundup of commercial stories appearing in Scrip's sister publication PharmAsia News, whose multilingual team of regional experts provides authoritative business intelligence focused on the Asian marketplace.</p><p>Full stories can be accessed by clicking on the title (subscription required).</p><p><p><a href="https://www.pharmamedtechbi.com/publications/pharmasia-news/2015/9/24/emerging-markets-rising-spending-seen-driving-generic-growth" target="_new">Emerging Markets' Rising Spending Seen Driving Generic Growth</a></p><p>The US has long been the Indian generic drug industry's biggest market but developing markets are also now emerging as important customers. Helped by acquisitions, geographic expansion and a steadily expanding product portfolio, India's top 10 pharma companies notched up a 21% CAGR in emerging market revenues from fiscal 2011-15, a new report says.</p><p><p><a href="https://www.pharmamedtechbi.com/publications/pharmasia-news/2015/9/23/guangzhou-lays-out-biopharma-welcome-mat-in-investment-push" target="_new">Guangzhou Lays Out Biopharma Welcome Mat In Investment Push</a></p><p>Guangzhou is planning to deepen investment in the biopharmaceutical industry and to formulate preferential policies and incentives to encourage tie-ups with multinational pharma firms. The provincial capital aims to develop the industry as a pillar sector that will contribute 15% of its GDP by 2025.</p><p><p><a href="https://www.pharmamedtechbi.com/publications/pharmasia-news/2015/9/23/lskbs-lead-project-set-for-phase-iii-gastric-cancer-trial" target="_new">LSKB's Lead Project Set For Phase III Gastric Cancer Trial</a></p><p>During an investor relations meeting in Seoul, South Korea's HLB talked about recent clinical R&D progress for the lead project at its subsidiary LSK BioPharma and its developing pipeline. LSK revealed it is set to begin global Phase III trials for apatinib in gastric cancer and also aims to move on to the clinical development of a newly licensed in BTK inhibitor within 2016.</p><p><p><a href="https://www.pharmamedtechbi.com/publications/pharmasia-news/2015/9/22/japan-pushing-forward-in-global-scrum-for-cancer-leads" target="_new">Japan Pushing Forward In Global Scrum For Cancer Leads</a></p><p>Japan is forging ahead with a national project to elucidate cancer-related gene alterations in its population, both to identify responder patients for possible inclusion in clinical trials for targeted therapies and to inform the development of new treatments.</p><p><p><a href="https://www.pharmamedtechbi.com/publications/pharmasia-news/2015/9/21/hisun-braces-for-hit-from-us-fda-import-alert" target="_new">Hisun Braces For Hit From US FDA Import Alert</a></p><p>Zhejiang Hisun Pharmaceutical has already seen its net profit slump this year, and now has to face a US import alert for APIs made at one of its Chinese plants on top of a voluntarily quarantine by importers in Canada. The company is nevertheless pushing ahead with the reconstruction of its business model, eyeing global partners for future markets.</p><p><p><a href="https://www.pharmamedtechbi.com/publications/pharmasia-news/2015/9/21/invest-in-indian-healthcare-to-boost-growth--or-lose-ground" target="_new">Invest In Indian Healthcare To Boost Growth - Or Lose Ground</a></p><p>India's healthcare needs have far outstripped the country's treatment capacities, meaning unless government and investors pump in more funds, a growing illness burden could hamper productivity and curb growth of Asia's third-largest economy, a new report warns.</p><p><p><a href="https://www.pharmamedtechbi.com/publications/pharmasia-news/2015/9/23/turkey-company-roundup-siemens-competition-probe-abraaj-investment" target="_new">Turkey Company Roundup: Siemens Competition Probe, Abraaj Investment</a></p><p>The Turkish Competition Authority has launched an investigation into Siemens, and the Abraaj Gorup has invested in a leading Turkish disposable medical supplies producer. Meanwhile, Abdi Ibrahim transfers a Croat director to its R&D department and Teknokim produces a cold chain monitoring indicator for the first time in Turkey.</p><p><p>www.pharmasianews.com</p>
----field----
field: {5BA0578F-65B7-4C22-8233-1603D698D8A4}
name: Summary
key: summary
content-length: 229

<p>A new regular roundup of commercial stories appearing in Scrip's sister publication PharmAsia News, whose multilingual team of regional experts provides authoritative business intelligence focused on the Asian marketplace.</p>
----field----
field: {8F4EE718-6FA0-42A5-85C4-6C8FE8B1FCD4}
name: Navigation Title
key: navigation title
content-length: 32

PharmAsia News Business Bulletin
----field----
field: {7C4FC796-1311-4DAA-81AC-85EAA2C1C108}
name: Actual Publish Date
key: actual publish date
content-length: 15

20150921T230000
----field----
field: {BDF7C8E1-869E-49FF-B9F5-854B3081A45D}
name: Created Date
key: created date
content-length: 15

20150921T230000
----field----
field: {C926A72A-39DA-446D-B78C-2A650F820A73}
name: Modified Date
key: modified date
content-length: 15

20150921T230000
----field----
field: {1616FE67-7278-4169-948E-C29B00EC8781}
name: Article Number
key: article number
content-length: 8

SC029876
----field----
field: {2C985172-2B37-4CFE-AEDE-2A42EC833941}
name: Content Type
key: content type
content-length: 38

{832554E5-EC9E-4747-8623-6770D36CAF32}
----field----
field: {31603F25-6D9C-4954-BCDE-342E1E184A30}
name: Meta Title Override
key: meta title override
content-length: 32

PharmAsia News Business Bulletin
----field----
field: {5AD65E47-7554-4CE5-87B0-7FB65051C05A}
name: Authors
key: authors
content-length: 38

{DB39CCA6-EB88-422C-8247-AB4AD01491E2}
----field----
field: {AE1BD751-D4E7-49CB-96C4-62E995A06B51}
name: Article Category
key: article category
content-length: 14

Market Insight
----field----
field: {0F6C8F42-01DC-4E05-B63E-AA25D8AA0E09}
name: Legacy Publication
key: legacy publication
content-length: 38

{0F9CCE10-91C1-4F31-832A-266F482A5DAF}
----field----
field: {5795FF15-0942-41FF-8A77-3B73185F5E1B}
name: Escenic ID
key: escenic id
content-length: 6

360598
----field----
field: {25BED78C-4957-4165-998A-CA1B52F67497}
name: __Created
key: __created
content-length: 16

20160209T042455Z
----field----
field: {5DD74568-4D4B-44C1-B513-0AF5F4CDA34F}
name: __Created by
key: __created by
content-length: 18

sitecore\Anonymous
----field----
field: {8CDC337E-A112-42FB-BBB4-4143751E123F}
name: __Revision
key: __revision
content-length: 36

8901c919-a66b-47d8-97e8-63406716736e
----field----
field: {D9CF14B1-FA16-4BA6-9288-E8A174D4D522}
name: __Updated
key: __updated
content-length: 16

20160209T042455Z
----field----
field: {BADD9CF9-53E0-4D0C-BCC0-2D784C282F6A}
name: __Updated by
key: __updated by
content-length: 18

sitecore\Anonymous
